Table 10 Univariate Analysis of the risk factors associated with MFS in patients with stage III NSCLC

Sex

0.103

0.748

 Male

102

 Female

41

Age (year)

5.438

0.020

  ≤ 65

47

 >65

96

Smoking status

0.208

0.720

 Ever smoker

73

 Never smoker

80

Tumor type

0.380

0.538

 SCC

60

 ADC

83

Use of ATB

14.181

< 0.001

 ATB

96

 Non-ATB

47

CD4+ (%)

21.643

< 0.001

 >32.10

109

  ≤ 32.10

34

CD8+ (%)

15.195

< 0.001

 >22.10

68

  ≤ 22.10

75

CD16 + 56+ (%)

14.124

< 0.001

 >10.88

109

  ≤ 10.88

34

D-Dimer (mg/L)

2.617

0.106

 >1.04

73

  ≤ 1.04

70

Treatment modalities

2.087

0.539

 Surgery

14

 Chemotherapy

89

 Targeted therapy

40

 Immunotherapy

12

 Radiotherapy

11